Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000-2014
Publication

Publications

Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000-2014

Title
Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000-2014
Type
Article in International Scientific Journal
Year
2019
Authors
Bhering, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Kritski, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Nunes, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Indexing
Other information
Authenticus ID: P-00R-661
Abstract (EN): SETTING: The incidence of tuberculosis (TB) has been decreasing in Portugal. Lisbon concentrates the largest number of cases of multidrug-resistant (MDR) TB in the country. This study aims at identifying clinical and demographic factors associated with unfavourable treatment results of patients with MDR-TB in the city. METHOD: The data on 265 MDR-TB cases, notified from 2000 to 2014 in the District of Lisbon, were collected from the Tuberculosis Surveillance System. Unfavourable cases were classified as failure, loss to follow-up (LTFU) and death. Bivariate and multivariate logistic regressions were undertaken to estimate the factors associated with unfavourable outcomes, LTFU and death. RESULTS: The proportion of unfavourable outcomes was 30.5%. These were associated mostly with being male, foreign-born and resistant to kanamycin. Death was associated with being human immunodeficiency virus-positive and resistant to kanamycin. Being foreign-born had a 4.46-fold higher odds of a LTFU outcome than did being Portuguese-born. The foreign-born patients were mostly African immigrants. CONCLUSION: The main finding in this study is that foreign-born patients are associated with a higher probability of unfavourable outcomes than Portuguese-born patients. Therefore, foreign-born patients need more careful monitoring in the control of MDR-TB.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The role of pre-migration medical screening in high TB burden countries (2017)
Another Publication in an International Scientific Journal
Duarte R
The impact of COVID-19 on the TB response: data from the field (2021)
Another Publication in an International Scientific Journal
Gigante, AR; Sousa, M; Aguiar, A; Pinto, M; Rita Gaio; Duarte R
Screening of refugees from Ukraine for TB: a TBnet survey (2024)
Another Publication in an International Scientific Journal
Lange, C; Duarte R; Duarte, R; Argel, M; Conde, M; Vieira, M
Relative cost of multidrug-resistant TB medicines in Europe (2023)
Another Publication in an International Scientific Journal
Günther G.; Guglielmetti L.; Leu C.; van Leth F.; Lange C.; Hafizi H.; Khachatryan N.; Aroyan H.; Kabasakalyan E.; Knappik M.; Skrahina A.; Klimuk D.; Nikolenka A.; Muylle I.; Milanov V.; Velkovska D.; Tarinska N.; Bachiyska E.; Jankovic M.; Pieridou D....(mais 70 authors)
Impact of COVID-19 on extrapulmonary TB and the benefit of decentralised TB services (2022)
Another Publication in an International Scientific Journal
Tinoco E.M.; Vasconcelos A.; Alves F.; Duarte R

See all (33)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-19 at 19:12:34 | Privacy Policy | Personal Data Protection Policy | Whistleblowing